New developments in the generation of ad-free, high-titer raav gene therapy vectors

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1295-1297

  Ferrari, Forrest K ^a   Xiao, Xiao ^a   McCarty, Doug ^a   Samulski, Richard J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL; CYSTIC FIBROSIS; DRUG CONTAMINATION; GENE THERAPY; GENE VECTOR; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; PHASE 1 CLINICAL TRIAL; REVIEW; TRANSGENE;

ADENOVIRIDAE; ANIMALS; CLINICAL TRIALS, PHASE I; CYSTIC FIBROSIS; DEPENDOVIRUS; DNA, VIRAL; DRUG CONTAMINATION; GENE THERAPY; GENETIC VECTORS; HUMANS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0031278324     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1197-1295     Document Type: Article

References (19)

1. Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. [Review] Curr. Top. Microbiol. Immunol. 158, 97-129 (1992).
2. Samulski, R.J. Adeno-associated virus-based vectors for human gene therapy, in Gene Therapy From Laboratory to the Clinic (ed. Hui, K.M.) 232-271 (World Scientific, Singapore, 1994).
3. Flotte, T.R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613-10617 (1993).
4. Monahan, P.E. et al. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. (in the press).
5. Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082-14087 (1996).
6. Xiao, X and Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8090-8108 (1996).
7. Kaplitt, M.G. et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154 (1994).
8. Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276 (1997).
9. Xiao, X., Li, J., McCown, T.J and Samulski, R.J. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp. Neurol. 144, 113-124 (1997).
10. Samulski, R.J., Chang, L.S and Shenk, T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101 (1987).
11. Samulski, R.J., Chang, L.S and Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828 (1989).
12. Clark, K.R., Voulgaropoulou, F., Fraley, D.M and Johnson, P.R. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341 (1995).
13. Flotte, T.R. et al. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2, 29-37 (1995).
14. Vincent, K.A., Piraino, S.T and Wadsworth, S.C. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71, 1897-1905 (1997).
15. Li, J., Samulski, R.J and Xiao, X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243 (1997).
16. Carter, B.J. Adeno-associated virus helper functions, in CRC Handbook of Parvoviruses Vol. 1 (ed. Tijssen, P.) 255-282 (CRC Press, Boca Raton, Florida, 1990).
17. McCoy, R.D. et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1553-1560 (1995).
18. Ferrari, F.K., Samulski, T., Shenk, T and Samulski, R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234 (1996).
19. Snyder, R.O., Xiao, X and Samulski, R.J. Production of recombinant adeno-associated viral vectors, in Current Protocols in Human Genetics (eds. Dracopoli, N, et al.) (John Wiley, New York, 1996).